CBLB產(chǎn)品信息
英文名稱:E3 ubiquitin-protein ligase CBL-B
中文名稱:E3泛素連接酶CBL-B
靶點(diǎn)別稱:CBLB,RNF56
物種:Human
屬性:Protein
標(biāo)記:Unconjugated
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in 40 mM HEPES, 120 mM NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
CBLB分子背景
Casitas B系淋巴瘤原癌基因B(CBLB)也被稱為RNF56。E3泛素蛋白連接酶從特定的E2泛素結(jié)合酶接受泛素,并將其轉(zhuǎn)移到底物上,通常促進(jìn)其被蛋白酶體降解。負(fù)調(diào)控TCR(T細(xì)胞受體)、BCR(B細(xì)胞受體)和FCER1(高親和力免疫球蛋白ε受體)信號(hào)轉(zhuǎn)導(dǎo)通路。輕微促進(jìn)SRC泛素化??赡軈⑴cEGFR泛素化和內(nèi)化??赡芘cE2泛素蛋白連接酶UB2D3功能偶聯(lián)。在胎盤、心臟、肺、腎臟、脾臟、卵巢和睪丸,以及胎兒腦、肝臟和造血細(xì)胞系中表達(dá),但在成人腦、肝臟、胰腺、唾液腺或骨骼肌中不表達(dá)。
關(guān)鍵字: CBLB;CBLB蛋白;CBLB重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。